Skip to content
drillr.ai
Sign up

002424.SZ

ST百灵

SZSE · Healthcare · C 制造业 · CN

CNY 4.55
+0.66%
Ask drillr

  • Aug 31, 2026, 09:11 UTC

    ST Bailing's wholly-owned subsidiary BaiLing Yuxiu (Zhuhai) Pharmaceutical Co., Ltd. received approval from the National Medical Products Administration to conduct clinical trials for the inhaled drug BD77 for chronic obstructive pulmonary disease.

  • Aug 28, 2026, 08:41 UTC

    ST Bailing's wholly-owned subsidiary received pre-approval from the Macao SAR Drug Administration (ISAF) to conduct a Phase III clinical trial for its traditional Chinese medicine product Tangningtongluo Tablet, the first such pre-approval for a new TCM drug in Macao.

    Source: